High Functioning Autism with Missense Mutations in Synaptotagmin-Like Protein 4 (SYTL4) and Transmembrane Protein 187...

Area of Science:

• Genetics
• Neuroscience
• Biochemistry

Background:

• Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with a significant genetic component.
• X-linked genes are increasingly recognized for their role in neurodevelopmental disorders, including ASD.
• Understanding the genetic underpinnings of ASD is crucial for developing targeted diagnostics and therapies.

Purpose of the Study:

• To investigate the potential role of rare variants in the Synaptotagmin-like protein 4 (SYTL4) and Transmembrane protein 187 (TMEM187) genes in a patient with high-functioning autism spectrum disorder (ASD).
• To analyze the in-silico predicted impact of identified variants on protein structure and function.
• To explore the interaction networks of SYTL4 and TMEM187 with known ASD-associated genes and microRNAs.

Main Methods:

• Genetic sequencing to identify variants in SYTL4 and TMEM187 genes.
• In-silico prediction tools (e.g., atomic threading models, multiple sequence alignments, hidden Markov models) to assess variant pathogenicity and structural impact.
• Literature-based analysis of gene-gene and gene-microRNA interactions with known ASD-associated factors.

Main Results:

• A rare missense variant (p.Arg279Cys) in SYTL4 was identified, predicted to cause structural changes affecting its RAB-Binding Domain.
• An unknown missense variant (p.Gln236His) in TMEM187 was identified, located near the protein's terminal region.
• Both SYTL4 and TMEM187 were found to interact with multiple known ASD-associated genes and microRNAs, suggesting a potential role in ASD pathogenesis.
• SYTL4 variants showed a low allele frequency (0.00042) in the European (Non-Finnish) population.
• Differential expression of microRNAs interacting with the mouse Sytl4 gene was observed in ASD individuals.

Conclusions:

• The identified rare variants in SYTL4 and TMEM187, coupled with their interactions with known ASD genes, position them as candidate genes for autism spectrum disorder.
• Further biological validation is necessary to confirm the pathogenicity of these variants in the causation of ASD.
• These findings highlight the importance of investigating X-linked genes and their complex interaction networks in understanding ASD etiology.